Pieris Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Checkpoint Capital (Master) Fund, LP(6.0%),Checkpoint Capital, LP(6.0%), etc.
Pieris Pharmaceuticals | SC 13G：超过5%持股股东披露文件-Checkpoint Capital (Master) Fund, LP(6.0%),Checkpoint Capital, LP(6.0%)等
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。